The Effect of Intermittent Rifampicin on Raltegravir
Clinical trial NCT01424826 · COMPLETED
Trial details
- NCT number
- NCT01424826
- Sponsor
- Helen Reynolds
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2013-06-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.